MARKET

XLO

XLO

Xilio Therapeutics, Inc.
NASDAQ
0.5802
-0.0160
-2.68%
After Hours: 0.5751 -0.0051 -0.88% 16:58 02/13 EST
OPEN
0.5798
PREV CLOSE
0.5962
HIGH
0.6030
LOW
0.5566
VOLUME
333.23K
TURNOVER
--
52 WEEK HIGH
1.700
52 WEEK LOW
0.5030
MARKET CAP
39.19M
P/E (TTM)
-0.8830
1D
5D
1M
3M
1Y
5Y
1D
Xilio Therapeutics Prices Pre-Funded Warrant Offering Financing
TipRanks · 1d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 1d ago
Xilio Therapeutics prices $40M stock offering
Seeking Alpha · 2d ago
*Xilio Therapeutics Prices Offering of Pre-Funded Warrants to Purchase 74.8M Shares >XLO
Dow Jones · 2d ago
*Xilio Therapeutics Expects Offering to Close on or About Feb. 13 >XLO
Dow Jones · 2d ago
*Xilio Therapeutics Plans to Use Net Proceeds to Advance Development of Its Product Candidates >XLO
Dow Jones · 2d ago
*Xilio Therapeutics Prices Pre-Funded Warrants at $0.5349 Each >XLO
Dow Jones · 2d ago
*Xilio Therapeutics Also Plans to Use Net Proceeds for Working Capital, Other General Corporate Purposes >XLO
Dow Jones · 2d ago
More
About XLO
Xilio Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. It is using its proprietary platform to build a pipeline of novel, tumor-activated I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines, antibodies, bispecific and immune cell engagers. Its pipeline products include Vilastobart (XTX101), XTX301, XTX501, and tumor-activated bispecific molecules and immune cell-engaging molecules. XTX101 is an investigational tumor-activated, Fc-enhanced, high-affinity binding anti-CTLA-4 monoclonal antibody. XTX301, a tumor-activated, engineered interleukin 12, or IL-12, therapy.

Webull offers Xilio Therapeutics Inc stock information, including NASDAQ: XLO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XLO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XLO stock methods without spending real money on the virtual paper trading platform.